Ziphius NV
Exhibitor
Ziphius NV is a Belgian biotechnology company developing vaccines and therapeutics based on its proprietary self-amplifying RNA and lipid nanoparticle platform. Founded in 2019 and headquartered in Zwijnaarde, the company is currently advancing a pipeline of infectious disease programs, including a prophylactic vaccine against Chlamydia trachomatis and a therapeutic vaccine against herpes simplex virus type 2.
Stay up-to-date
Join our mailing list to receive exclusive content and offers.
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events